Cannot cut corners' in approving Covaxin, says WHO

The global health agency also emphasized that it must evaluate a vaccine thoroughly to make sure it is "safe and effective".

The World Health Organisation (WHO) on Monday said it was expecting additional information from India's Bharat Biotech regarding its COVID-19 jab Covaxin, asserting that it "cannot cut corners" before recommending a vaccine for emergency use.

The global health agency also emphasized that it must evaluate a vaccine thoroughly to make sure it is "safe and effective". Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use Listing (EUL).